SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-202165
Filing Date
2021-06-28
Accepted
2021-06-28 17:11:05
Documents
5
Period of Report
2021-08-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A d101884ddef14a.htm DEF 14A 1233914
2 GRAPHIC g101884dsp001c.jpg GRAPHIC 832
3 GRAPHIC g101884g001.jpg GRAPHIC 2291
4 GRAPHIC g101884g45j41.jpg GRAPHIC 26407
5 GRAPHIC g101884g88a96.jpg GRAPHIC 26217
  Complete submission text file 0001193125-21-202165.txt   1309064
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37627 | Film No.: 211054431
SIC: 2834 Pharmaceutical Preparations